Article
Activity of Ceftazidime-Avibactam Against Clinical Isolates of Klebsiella pneumoniae, Including KPC-Carrying Isolates, Endemic to New York City.
Microbial drug resistance (Larchmont, N.Y.) - 1 Jan 2000
Manning Nyla, Balabanian Gregory, Rose Michael, Landman David, Quale John
Abstract excerpt
In this report, we examined the (1) activity of ceftazidime-avibactam against clinical isolates Klebsiella pneumoniae, including those harboring blaKPC, (2) potential mechanisms leading to reduced susceptibility, and (3) activity of ceftazidime-avibactam when combined with other agents. Of 802 carbapenem-resistant isolates of K. pneumoniae gathered from New York City from 1999 to 2014, all were susceptible to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.